| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2019 | Liffman Joel D | SVP, Finance | Sale+OE | 3,725 | $7.03 | $26,186.75 | -4.2% | |
| Jan 3, 2019 | Lehr Donald P.75 | Chief Legal Officer | Sale+OE | 3,832 | $7.07 | $27,094.16 | -10.1% | |
| Jan 3, 2019 | Reed Thomas D. | Chief Science Officer | Sale+OE | 2,944 | $7.07 | $20,815.55 | -3.6% | |
| Jan 3, 2019 | Sterling Rick L. | Chief Financial Officer | Sale+OE | 3,514 | $7.07 | $24,845.74 | -4.2% | |
| Jan 3, 2019 | Perez Jeffrey Thomas71 | SVP, Ip Affairs | Sale+OE | 3,514 | $7.07 | $24,845.74 | -15.8% | |
| Jan 3, 2019 | Sabzevari Helen75 | President, Precigen, Inc. | Sale+OE | 3,832 | $7.07 | $27,094.16 | -14.5% | |
| Jan 3, 2019 | Nimrodi Nir | Chief Business Officer | Sale+OE | 4,058 | $7.07 | $28,692.09 | -41.6% | |
| Jan 3, 2019 | Walsh Robert F. III | SVP, Energy &Fine Chem. | Sale+OE | 4,058 | $7.07 | $28,691.68 | -41.6% | |
| Dec 31, 2018 | Reed Thomas D. | Chief Science Officer | Sell | 30,000 | $6.36 | $190,671.00 | -29.2% | |
| Oct 15, 2018 | Liffman Joel D | SVP, Finance | Sell | 79,000 | $14.59 | $1,152,807.50 | -49.8% |